Incentives to Pharma Companies but Health Care Leaders Voice Doubts on Smallpox Inoculations Thu, 30 Jan 2003 The New York Times reports (below) that serious doubts about the president’s smallpox vaccination plan emerged at a Senate hearing Wednesday. The Washington Post reports (below) that "The hearing illustrated the growing tensions…
Yesterday we forwarded an article about Tylenol-linked liver damage published by Associated Press. https://ahrp.org/cms/content/view/278/28/
Below two recent reports by Counterpunch.
An investigative report in The Philadelphia Inquirer examined pharmaceutical company ties to six, tax exempt organziations that identify themselves as “patient advocacy” groups, "Each a leading advocate for patients in a disease area.”
"Lobbyists influence how the government spends your money, but financially conflicted physicians can threaten your well-being."
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
FDA political appointees have embarked on a plan to divest the American consumer of the right to seek compensation for defective prescription drugs.
The year 2005 will surely be the year in which the pharmaceutical industry’s
dirty tricks and underhanded tactics were revealed for what they are–a
menace to society.
"Every year, drug companies spend $14 billion to test experimental substances on humans. Across the U.S., the centers that do the testing–and the regulators who watch them–allow scores of human test subjects to be injured or killed."
Tom Cruise re-ignited the debate about psychiatry–its false claims & drug hazards – Florida Medicaid restricts Fri, 01 Jul 2005 Tom Cruise “kicked off a debate over a subject that a lot of people don’t feel comfortable discussing: whether Americans are too quick to turn to prescription drugs and whether…
Conflict of Interest: Profits vs Safety Congressional Investigations US Senators Pharmaceutical industry holdings, 2004: http://www.consumerwatchdog.org/resources/SenPharma.pdf Oct 12: How Did the Vioxx Debacle Happen? USA Today / Lancet Oct 4: Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical…
LA Times: NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling Fri, 22 Apr 2005 Pulitzer Prize winner David Willman of the Los Angeles Times, whose investigative reporting first revealed the major covert conflicts of interest among top scientists and administrators at the National Institutes of Health (NIH), reports…
NAMI & Eli Lilly partners in bankrupting state Medicaid budgets – NYT Sat, 20 Dec 2003 The New York Times reports that Medicaid expenditure for prescription drugs has escalated to $27.5 billion. These costs are up 19% from last year. Antipsychotic drugs, such as Eli Lilly’s Zyprexa, eat up more…
